Harvey Capital Management Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Harvey capital management inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Harvey Capital Management Inc Today - Breaking & Trending Today

Evoke Wealth LLC Makes New $1.36 Million Investment in Halozyme Therapeutics, Inc. (NASDAQ:HALO)

Evoke Wealth LLC purchased a new position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 36,657 shares of the biopharmaceutical company’s stock, valued at approximately $1,355,000. A number of other […] ....

United States , Michaelj Labarre , Norges Bank , Exchange Commission , Securities Exchange Commission , International Assets Investment Management , Wafra Inc , Halozyme Therapeutics Inc , Harvey Capital Management Inc , Evoke Wealth , Halozyme Therapeutics , Free Report , Assets Investment Management , Capital Management , Get Free Report , Halozyme Therapeutics Daily ,

TD Asset Management Inc Increases Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)

TD Asset Management Inc Increases Holdings in Halozyme Therapeutics, Inc. (NASDAQ:HALO)
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United States , Michaelj Labarre , Harvey Capital Management Inc , Hsbc Holdings , Wafra Inc , Exchange Commission , Halozyme Therapeutics Company Profile , Securities Exchange Commission , Td Asset Management Inc , International Assets Investment Management , Halozyme Therapeutics Inc , Management Inc , Halozyme Therapeutics , Free Report , Assets Investment Management , Capital Management , Therapeutics Stock Down , Get Free Report , Visit Holdingschannel , Halozyme Therapeutics Daily ,

Halozyme Therapeutics' (HALO) "Buy" Rating Reiterated at HC Wainwright

HC Wainwright reiterated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) in a report issued on Wednesday, Benzinga reports. The firm currently has a $50.00 price objective on the biopharmaceutical company’s stock. Other equities research analysts also recently issued research reports about the stock. TD Cowen began coverage on shares of […] ....

United States , Michaelj Labarre , Halozyme Therapeutics Company Profile , Wafra Inc , Hsbc Holdings , International Assets Investment Management , Halozyme Therapeutics Inc , Harvey Capital Management Inc , Halozyme Therapeutics , Free Report , Moderate Buy , Therapeutics Stock Down , Assets Investment Management , Capital Management , Get Free Report , Halozyme Therapeutics Daily ,

HC Wainwright Reaffirms Buy Rating for Halozyme Therapeutics (NASDAQ:HALO)

HC Wainwright restated their buy rating on shares of Halozyme Therapeutics (NASDAQ:HALO – Free Report) in a research note released on Wednesday morning, Benzinga reports. They currently have a $50.00 target price on the biopharmaceutical company’s stock. Other analysts have also issued reports about the stock. JMP Securities cut their target price on shares of […] ....

United States , Michaelj Labarre , Hsbc Holdings , Wafra Inc , International Assets Investment Management , Securities Exchange Commission , Halozyme Therapeutics Inc , Harvey Capital Management Inc , Halozyme Therapeutics , Free Report , Moderate Buy , Get Free Report , Exchange Commission , Assets Investment Management , Capital Management , Halozyme Therapeutics Daily ,

Halozyme Therapeutics, Inc. (NASDAQ:HALO) Shares Purchased by Gallacher Capital Management LLC

Gallacher Capital Management LLC boosted its position in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 85.2% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 11,403 shares of the biopharmaceutical company’s stock after acquiring an additional 5,245 shares during the period. […] ....

United States , Michaelj Labarre , Halozyme Therapeutics Company Profile , Allspring Global Investments Holdings , Goldman Sachs Group , Gallacher Capital Management , Halozyme Therapeutics Inc , Hsbc Holdings , Securities Exchange Commission , Harvey Capital Management Inc , International Assets Investment Management , Halozyme Therapeutics , Free Report , Capital Management , Assets Investment Management , Global Investments Holdings , Aurora Investment Counsel , Exchange Commission , Get Free Report , Visit Holdingschannel , Halozyme Therapeutics Daily , Nasdaq Halo , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,